About this trial
The purpose of this multi-center, randomized controlled trial is to investigate the acute effects of the standard Laura Mitchell Physiological Relaxation Method versus a Modified Mitchell Relaxation Version on cardiac autonomic modulation (heart rate variability). The study will include 122 participants aged 18-65 who score 10 or higher on the Generalized Anxiety Disorder-7 (GAD-7) scale, indicating high anxiety and potentially reduced parasympathetic control. Participants will be randomly allocated into two equal groups (n=61 per group) using a block randomization system with a concealed envelope method. To control for expectation bias, an incomplete disclosure protocol will be utilized, ensuring participants remain blinded to their specific group allocation. Both interventions will last 35 minutes and will be delivered via audio recordings in a supine position (Mitchell's 'Position A') to prevent investigator bias. Cardiac autonomic responses will be assessed using a Polar H10 chest strap to analyze Heart Rate Variability (HRV) before, during, and after the sessions. Blood pressure and respiration rate will also be monitored as secondary outcomes
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Being 18-65 years old.
Having stress and anxiety
Disqualifiers
Taking cardioactive/psychotropic drugs.
Having a diagnosis of cardiovascular disease.
Trial design
Parallel
Treatments tested in this trial
Modified Mitchell Relaxation Exercises
Other interventionModified Relaxation Exercises based on Muscle Energy Technique, Deep Breathing, Additional Natural Relxation Postures in addition Skin and Proprioceptive Awareness and Reciprocal Mussle .
Standard Mitchell Relaxation Exercise
Other interventionOriginal Relaxation Exercises based on Skin and Proprioceptive Awareness and Reciprocal Mussle Inhibition
Treatment groups
Trial outcomes
Primary outcomes
RMSSD - Root Mean Square of Succesive Differences of RR Peaks of EKG
Root Mean Square of Succesive Differences of RR Peaks of EKG
Secondary outcomes
Time-Domain Heart Rate Variability Parameters (SDNN, RMSSD, Mean RR Interval)
Time-domain HRV parameters, including the standard deviation of NN intervals (SDNN), the root mean square of successive differences between normal heartbeats (RMSSD), and mean RR interval duration, will be calculated from continuous ECG/PPG recordings. \[Unit: milliseconds\]
Absolute Spectral Power HRV Parameters (LF, HF)
Low-frequency (LF, 0.04-0.15 Hz) and high-frequency (HF, 0.15-0.4 Hz) spectral power components of heart rate variability will be calculated from RR interval series using power spectral density analysis. \[Unit: ms²\]
LF/HF Ratio
The ratio of low-frequency to high-frequency spectral power, reflecting sympathovagal balance, will be calculated from RR interval series. \[Unit: ratio (unitless)\]
Poincaré Plot HRV Parameters (SD1, SD2)
Standard deviation of the Poincaré plot perpendicular to the line of identity (SD1) and along the line of identity (SD2), reflecting short- and long-term heart rate variability, will be calculated from RR interval series. \[Unit: milliseconds\]
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: